These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2935106)

  • 1. Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension.
    Pedrinelli R; Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Arch Intern Med; 1986 Jan; 146(1):62-5. PubMed ID: 2935106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
    Bauer JH; Sunderrajan S; Reams G
    Am J Cardiol; 1985 Dec; 56(16):62H-67H. PubMed ID: 2933950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and systemic hemodynamic effects of nitrendipine.
    Fouad FM; Pedrinelli R; Bravo EL; Abi-Samra F; Textor SC; Tarazi RC
    Clin Pharmacol Ther; 1984 Jun; 35(6):768-75. PubMed ID: 6734029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension.
    Ventura HO; Messerli FH; Oigman W; Dunn FG; Reisin E; Frohlich ED
    Am J Cardiol; 1983 Mar; 51(5):783-6. PubMed ID: 6829438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a calcium entry blocker on blood pressure and renal function during angiotensin-induced hypertension.
    Huelsemann JL; Sterzel RB; McKenzie DE; Wilcox CS
    Hypertension; 1985; 7(3 Pt 1):374-9. PubMed ID: 3158602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age related antihypertensive effect of nitrendipine, a new calcium entry blocking agent.
    Ferrara LA; Fasano ML; Soro S
    Eur J Clin Pharmacol; 1985; 28(4):473-4. PubMed ID: 3161743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjects.
    Laederach K; Weidmann P; Lauener F; Gerber A; Ziegler WH
    J Cardiovasc Pharmacol; 1986; 8(2):294-302. PubMed ID: 2422467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and regional hemodynamics in normotensive and spontaneously hypertensive rats after slow-channel calcium blocker nitrendipine.
    Sesoko S; Pegram BL; Frohlich ED
    Clin Exp Hypertens A; 1984; 6(5):979-91. PubMed ID: 6733943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.
    London GM; Pannier B; Guerin AP; Marchais SJ; Safar ME; Cuche JL
    Circulation; 1994 Dec; 90(6):2786-96. PubMed ID: 7994822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The specificity of the hypotensive effect of calcium antagonists in hypertension].
    Ivleva AIa; Kobalava ZhD; Antiia ID; Krasnobaeva GM; Iartsev VE; Lepakhin VK; Moiseev VS
    Ter Arkh; 1991; 63(9):97-100. PubMed ID: 1759235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs.
    Knight DR; Kirby DA; Vatner SF
    Hypertension; 1985; 7(3 Pt 1):380-5. PubMed ID: 3158603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine.
    Fouad FM; Aboul-Khair M; Tarazi RC
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S383-6. PubMed ID: 6184573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term effects of calcium entry blockers on the kidney.
    Bauer JH; Reams G
    Am J Cardiol; 1987 Jan; 59(2):66A-71A. PubMed ID: 3544786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.